Emcure Pharma IPO KPI Information
The Emcure Pharma IPO KPI (Key Performance Indicators) provide valuable insights into the company's financial efficiency, profitability, and capital utilization. Key metrics such as Return on Equity (ROE), Return on Capital Employed (ROCE), Debt-to-Equity Ratio, Return on Net Worth (RoNW), Price-to-Book Value (P/BV), and PAT Margin help investors evaluate the company's operational performance and financial health before investing in the IPO.
Based on the latest reported financial year (KPI Information), Emcure Pharmaceuticals Limited reported ROE of 16.9%, ROCE of 19.37%, RoNW of 16.87%, Debt-to-Equity Ratio of 0.67, and Price-to-Book Value (P/BV) of 6.18. These key financial ratios provide investors with a snapshot of the company's profitability, capital efficiency, leverage, and overall financial strength.
Emcure Pharma IPO Key Performance Indicators
- Return on Equity (ROE): 16.9%
- Return on Capital Employed (ROCE): 19.37%
- Return on Net Worth (RoNW): 16.87%
- Debt-to-Equity Ratio: 0.67
- Price-to-Book Value (P/BV): 6.18
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Emcure Pharmaceuticals Limited KPI Information
| Particular | KPI Information |
|---|---|
| ROE % | 16.9 |
| ROCE % | 19.37 |
| Debt / Equity | 0.67 |
| RoNW % | 16.87 |
| PbW | 6.18 |
Return Ratio
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Market Cap of Emcure Pharmaceuticals Limited?
The post-IPO market capitalisation (market cap) of Emcure Pharmaceuticals Limited is approximately ₹19,029.89 crore, based on the IPO issue price and the company's post-issue equity share capital. Market cap represents the total market value of a company's outstanding shares and is widely used by investors to assess the company's size and valuation.
What is the ROE of Emcure Pharmaceuticals Limited?
Emcure Pharmaceuticals Limited reported a Return on Equity (ROE) of 16.9% as of KPI Information. ROE measures how efficiently the company generates profits from shareholders' equity. A higher ROE generally indicates strong financial performance and effective management of shareholder funds.
What is the ROCE of Emcure Pharmaceuticals Limited?
The Return on Capital Employed (ROCE) of Emcure Pharmaceuticals Limited stood at 19.37% as of KPI Information. ROCE measures how efficiently the company uses its total capital to generate profits. A higher ROCE indicates better capital efficiency and operational performance.
What is the Net Profit Margin (PAT Margin) of Emcure Pharmaceuticals Limited?
Emcure Pharmaceuticals Limited reported a Profit After Tax (PAT) Margin of 0% as of KPI Information. PAT Margin shows the percentage of revenue that remains as net profit after all operating expenses, interest, and taxes. A higher margin reflects better profitability and cost management.
What is the Return on Net Worth (RoNW) of Emcure Pharmaceuticals Limited?
The Return on Net Worth (RoNW) of Emcure Pharmaceuticals Limited was 16.87% as of KPI Information. RoNW measures the company's ability to generate profits from shareholders' net worth and is an important indicator of overall financial efficiency.